LOADING
Comparing Merck & Company (MRK) and Snap Inc (SNAP) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | SNAP |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $274.8B | $9.5B |
| P/E Ratio | 31.4 | -- |
| Forward P/E | 22.0 | 12.7 |
| PEG Ratio | 5.18 | 496.06 |
| EPS | $3.55 | $-0.24 |
| Revenue Growth (YoY) | 4.9% | 12.1% |
| Profit Margin | 13.6% | -6.7% |
| Return on Equity | 18.9% | -18.6% |
| Dividend Yield | 2.94% | -- |
| Beta | 0.20 | 1.05 |
| 52-Week High | $124.22 | $10.41 |
| 52-Week Low | $70.74 | $3.81 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.